H. Pylori May Hinder Efficacy of Immune Checkpoint Inhibitors H. Pylori May Hinder Efficacy of Immune Checkpoint Inhibitors

Helicobacter pylori decreased the efficacy of immune checkpoint inhibitors in mice and was associated with a less efficacious response to therapy in a retrospective study of nonsmall-cell lung cancer patients, researchers say.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news